-
Je něco špatně v tomto záznamu ?
Avidity of anticardiolipin antibodies - a factor that could be important for their detection by ELISA methods
Lenka Fialová, Ivan Malbohan, Karin Malíčková
Jazyk angličtina Země Česko
Typ dokumentu práce podpořená grantem, hodnotící studie
- MeSH
- afinita protilátek * imunologie MeSH
- antikardiolipinové protilátky * imunologie MeSH
- autoimunitní nemoci krev MeSH
- dospělí MeSH
- ELISA * MeSH
- imunoglobulin G imunologie MeSH
- lidé středního věku MeSH
- lidé MeSH
- močovina imunologie MeSH
- senioři MeSH
- senzitivita a specificita MeSH
- sérum imunologie MeSH
- techniky in vitro statistika a číselné údaje MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- hodnotící studie MeSH
- práce podpořená grantem MeSH
Avidity is an important feature of antibodies associated with their pathogenic effects. Anticardiolipin antibodies (aCLs) are the most commonly examined antiphospholipid antibodies, however, their avidity has been investigated only marginally. The aim of the study was to compare the avidity of the antibodies specifically bound to the cardiolipin-coated microtitrate wells with those bound to the wells bearing no cardiolipin in various conditions. We analysed 22 serum samples with high, medium and low levels of aCL IgG. The avidity of aCL IgG was determined in serially diluted sera by the ELISA method in the presence of increasing urea concentrations (from 2 to 8 mol/L) as a chaotropic agent. The serum dilution 1:50 and 1:100 and the concentrations of urea 6 mol/L and 8 mol/L seemed to be suitable for the determination of aCL avidity. The avidity of antibodies specifically bound to the cardiolipin and those bound to the cardiolipin-free wells significantly differed in their avidity. The simultaneous determination of higher-avidity aCL and lower-avidity polyspecific antibodies, whose presence complicates the ELISA methods by an increase of the background signal, might limit the shortcomings of some ELISA methods.
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15018293
- 003
- CZ-PrNML
- 005
- 20151009155817.0
- 007
- ta
- 008
- 150525s2014 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $2 doi $a 10.1016/j.jab.2014.01.005
- 040 __
- $a ABA008 $d ABA008 $e AACR2 $b cze
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Fialová, Lenka, $7 xx0074272 $u Charles University in Prague and General University Hospital in Prague, First Faculty of Medicine, Institute of Medical Biochemistry and Laboratory Medicine, Prague $d 1957-
- 245 10
- $a Avidity of anticardiolipin antibodies - a factor that could be important for their detection by ELISA methods / $c Lenka Fialová, Ivan Malbohan, Karin Malíčková
- 504 __
- $a Literatura
- 520 9_
- $a Avidity is an important feature of antibodies associated with their pathogenic effects. Anticardiolipin antibodies (aCLs) are the most commonly examined antiphospholipid antibodies, however, their avidity has been investigated only marginally. The aim of the study was to compare the avidity of the antibodies specifically bound to the cardiolipin-coated microtitrate wells with those bound to the wells bearing no cardiolipin in various conditions. We analysed 22 serum samples with high, medium and low levels of aCL IgG. The avidity of aCL IgG was determined in serially diluted sera by the ELISA method in the presence of increasing urea concentrations (from 2 to 8 mol/L) as a chaotropic agent. The serum dilution 1:50 and 1:100 and the concentrations of urea 6 mol/L and 8 mol/L seemed to be suitable for the determination of aCL avidity. The avidity of antibodies specifically bound to the cardiolipin and those bound to the cardiolipin-free wells significantly differed in their avidity. The simultaneous determination of higher-avidity aCL and lower-avidity polyspecific antibodies, whose presence complicates the ELISA methods by an increase of the background signal, might limit the shortcomings of some ELISA methods.
- 650 12
- $a antikardiolipinové protilátky $x imunologie $7 D017153
- 650 12
- $a afinita protilátek $x imunologie $7 D000915
- 650 12
- $a ELISA $7 D004797
- 650 _2
- $a sérum $x imunologie $7 D044967
- 650 _2
- $a močovina $x imunologie $7 D014508
- 650 _2
- $a techniky in vitro $x statistika a číselné údaje $7 D066298
- 650 _2
- $a imunoglobulin G $x imunologie $7 D007074
- 650 _2
- $a senzitivita a specificita $7 D012680
- 650 _2
- $a autoimunitní nemoci $x krev $7 D001327
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a hodnotící studie $7 D023362
- 700 1_
- $a Matouš-Malbohan, Ivan, $d 1943- $7 xx0104988 $u Charles University in Prague and General University Hospital in Prague, First Faculty of Medicine, Institute of Medical Biochemistry and Laboratory Medicine, Prague
- 700 1_
- $a Černá, Karin $7 xx0096040 $u Charles University in Prague and General University Hospital in Prague, First Faculty of Medicine, Institute of Medical Biochemistry and Laboratory Medicine, Prague
- 773 0_
- $t Journal of applied biomedicine $x 1214-021X $g Roč. 12, č. 4 (2014), s. 277-284 $w MED00012667
- 856 41
- $u https://jab.zsf.jcu.cz/pdfs/jab/2014/04/12.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b B 2301 $c 1249 $y 4 $z 0
- 990 __
- $a 20150522215938 $b ABA008
- 991 __
- $a 20151009160001 $b ABA008
- 999 __
- $a ok $b bmc $g 1078526 $s 901224
- BAS __
- $a 3
- BMC __
- $a 2014 $b 12 $c 4 $d 277-284 $i 1214-021X $m Journal of Applied Biomedicine $x MED00012667
- LZP __
- $c NLK121 $d 20151009 $a NLK 2015-26/dk